Literature DB >> 27143409

The Pathogenesis of the Demyelinating Form of Guillain-Barre Syndrome (GBS): Proteo-peptidomic and Immunological Profiling of Physiological Fluids.

Rustam H Ziganshin1, Olga M Ivanova2, Yakov A Lomakin2, Alexey A Belogurov2, Sergey I Kovalchuk2, Igor V Azarkin2, Georgij P Arapidi3, Nikolay A Anikanov2, Victoria O Shender2, Mikhail A Piradov4, Natalia A Suponeva4, Anna A Vorobyeva4, Alexander G Gabibov2, Vadim T Ivanov2, Vadim M Govorun5.   

Abstract

Acute inflammatory demyelinating polyneuropathy (AIDP) - the main form of Guillain-Barre syndrome-is a rare and severe disorder of the peripheral nervous system with an unknown etiology. One of the hallmarks of the AIDP pathogenesis is a significantly elevated cerebrospinal fluid (CSF) protein level. In this paper CSF peptidome and proteome in AIDP were analyzed and compared with multiple sclerosis and control patients. A total protein concentration increase was shown to be because of even changes in all proteins rather than some specific response, supporting the hypothesis of protein leakage from blood through the blood-nerve barrier. The elevated CSF protein level in AIDP was complemented by activization of protein degradation and much higher peptidome diversity. Because of the studies of the acute motor axonal form, Guillain-Barre syndrome as a whole is thought to be associated with autoimmune response against neurospecific molecules. Thus, in AIDP, autoantibodies against cell adhesion proteins localized at Ranvier's nodes were suggested as possible targets in AIDP. Indeed, AIDP CSF peptidome analysis revealed cell adhesion proteins degradation, however no reliable dependence on the corresponding autoantibodies levels was found. Proteome analysis revealed overrepresentation of Gene Ontology groups related to responses to bacteria and virus infections, which were earlier suggested as possible AIDP triggers. Immunoglobulin blood serum analysis against most common neuronal viruses did not reveal any specific pathogen; however, AIDP patients were more immunopositive in average and often had polyinfections. Cytokine analysis of both AIDP CSF and blood did not show a systemic adaptive immune response or general inflammation, whereas innate immunity cytokines were up-regulated. To supplement the widely-accepted though still unproven autoimmunity-based AIDP mechanism we propose a hypothesis of the primary peripheral nervous system damaging initiated as an innate immunity-associated local inflammation following neurotropic viruses egress, whereas the autoantibody production might be an optional complementary secondary process.
© 2016 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27143409      PMCID: PMC4937510          DOI: 10.1074/mcp.M115.056036

Source DB:  PubMed          Journal:  Mol Cell Proteomics        ISSN: 1535-9476            Impact factor:   5.911


  72 in total

1.  The intrathecal humoral immune response: laboratory analysis and clinical relevance.

Authors:  C J Sindic; M P Van Antwerpen; S Goffette
Journal:  Clin Chem Lab Med       Date:  2001-04       Impact factor: 3.694

2.  Ranvier revisited: novel nodal antigens stimulate interest in GBS pathogenesis.

Authors:  Hugh Willison; Steven S Scherer
Journal:  Neurology       Date:  2014-06-11       Impact factor: 9.910

3.  Expression of TNFalpha and TGFbeta1 in Guillain-Barré syndrome: correlation of a low TNFalpha-/TGFbeta1-mRNA ratio with good recovery and signs for immunoregulation within the cerebrospinal fluid compartment.

Authors:  L M Ossege; E Sindern; B Voss; J P Malin
Journal:  Eur J Neurol       Date:  2000-01       Impact factor: 6.089

4.  Isolated blood-cerebrospinal fluid barrier dysfunction: prevalence and associated diseases.

Authors:  J Brettschneider; A Claus; J Kassubek; H Tumani
Journal:  J Neurol       Date:  2005-04-01       Impact factor: 4.849

5.  Proteomic identification of potential protein markers in cerebrospinal fluid of GBS patients.

Authors:  T Jin; L-S Hu; M Chang; J Wu; B Winblad; J Zhu
Journal:  Eur J Neurol       Date:  2007-05       Impact factor: 6.089

Review 6.  Guillain-Barré syndrome.

Authors:  V Cosi; M Versino
Journal:  Neurol Sci       Date:  2006-03       Impact factor: 3.307

7.  Guillain-Barré Syndrome outbreak associated with Zika virus infection in French Polynesia: a case-control study.

Authors:  Van-Mai Cao-Lormeau; Alexandre Blake; Sandrine Mons; Stéphane Lastère; Claudine Roche; Jessica Vanhomwegen; Timothée Dub; Laure Baudouin; Anita Teissier; Philippe Larre; Anne-Laure Vial; Christophe Decam; Valérie Choumet; Susan K Halstead; Hugh J Willison; Lucile Musset; Jean-Claude Manuguerra; Philippe Despres; Emmanuel Fournier; Henri-Pierre Mallet; Didier Musso; Arnaud Fontanet; Jean Neil; Frédéric Ghawché
Journal:  Lancet       Date:  2016-03-02       Impact factor: 79.321

8.  Electrophysiological classification of Guillain-Barré syndrome: clinical associations and outcome. Plasma Exchange/Sandoglobulin Guillain-Barré Syndrome Trial Group.

Authors:  R D Hadden; D R Cornblath; R A Hughes; J Zielasek; H P Hartung; K V Toyka; A V Swan
Journal:  Ann Neurol       Date:  1998-11       Impact factor: 10.422

9.  Microscale depletion of high abundance proteins in human biofluids using IgY14 immunoaffinity resin: analysis of human plasma and cerebrospinal fluid.

Authors:  Seok-Won Hyung; Paul D Piehowski; Ronald J Moore; Daniel J Orton; Athena A Schepmoes; Therese R Clauss; Rosalie K Chu; Thomas L Fillmore; Heather Brewer; Tao Liu; Rui Zhao; Richard D Smith
Journal:  Anal Bioanal Chem       Date:  2014-09-06       Impact factor: 4.142

10.  Peptidome analysis of cerebrospinal fluid by LC-MALDI MS.

Authors:  Mikko Hölttä; Henrik Zetterberg; Ekaterina Mirgorodskaya; Niklas Mattsson; Kaj Blennow; Johan Gobom
Journal:  PLoS One       Date:  2012-08-06       Impact factor: 3.240

View more
  16 in total

1.  Respiratory Pathways Reconstructed by Multi-Omics Analysis in Melioribacter roseus, Residing in a Deep Thermal Aquifer of the West-Siberian Megabasin.

Authors:  Sergey Gavrilov; Olga Podosokorskaya; Dmitry Alexeev; Alexander Merkel; Maria Khomyakova; Maria Muntyan; Ilya Altukhov; Ivan Butenko; Elizaveta Bonch-Osmolovskaya; Vadim Govorun; Ilya Kublanov
Journal:  Front Microbiol       Date:  2017-06-30       Impact factor: 5.640

Review 2.  Immunotherapy of Guillain-Barré syndrome.

Authors:  Shuang Liu; Chaoling Dong; Eroboghene Ekamereno Ubogu
Journal:  Hum Vaccin Immunother       Date:  2018-07-12       Impact factor: 3.452

3.  COVID-19-Associated Bifacial Weakness with Paresthesia Subtype of Guillain-Barré Syndrome.

Authors:  K L Hutchins; J H Jansen; A D Comer; R V Scheer; G S Zahn; A E Capps; L M Weaver; N A Koontz
Journal:  AJNR Am J Neuroradiol       Date:  2020-06-25       Impact factor: 3.825

Review 4.  Biology of the human blood-nerve barrier in health and disease.

Authors:  Eroboghene E Ubogu
Journal:  Exp Neurol       Date:  2020-03-03       Impact factor: 5.330

5.  Are Repeated Cycles of Intravenous Immunoglobulin Justified in Patients With Poorly Responsive Guillain-Barré Syndrome?

Authors:  Hussein Algahtani; Bader Shirah; Khalid Alrefaei; Mohammed Albassam; Nawal Abdelghaffar
Journal:  Neurohospitalist       Date:  2019-12-13

6.  Elevated cerebrospinal fluid levels of beta-2-microglobulin in patients with Guillain-Barré syndrome and their correlations with clinical features.

Authors:  Ming-Qi Liu; Jing Wang; Chen-Na Huang; Yuan Qi; Lin-Jie Zhang; Ming Yi; Sheng-Hui Chang; Li-Sha Sun; Li Yang
Journal:  Neurol Sci       Date:  2021-02-17       Impact factor: 3.307

7.  Drift of the Subgingival Periodontal Microbiome during Chronic Periodontitis in Type 2 Diabetes Mellitus Patients.

Authors:  Irina P Balmasova; Evgenii I Olekhnovich; Ksenia M Klimina; Anna A Korenkova; Maria T Vakhitova; Elmar A Babaev; Leyla A Ovchinnikova; Yakov A Lomakin; Ivan V Smirnov; Victor N Tsarev; Ashot M Mkrtumyan; Alexey A Belogurov; Alexander G Gabibov; Elena N Ilina; Sergey D Arutyunov
Journal:  Pathogens       Date:  2021-04-22

8.  Phase Transition of the Bacterium upon Invasion of a Host Cell as a Mechanism of Adaptation: a Mycoplasma gallisepticum Model.

Authors:  Daria Matyushkina; Olga Pobeguts; Ivan Butenko; Anna Vanyushkina; Nicolay Anikanov; Olga Bukato; Daria Evsyutina; Alexandra Bogomazova; Maria Lagarkova; Tatiana Semashko; Irina Garanina; Vladislav Babenko; Maria Vakhitova; Valentina Ladygina; Gleb Fisunov; Vadim Govorun
Journal:  Sci Rep       Date:  2016-10-24       Impact factor: 4.379

9.  Epitope-Specific Response of Human Milk Immunoglobulins in COVID-19 Recovered Women.

Authors:  Tatyana V Bobik; Nikita N Kostin; George A Skryabin; Polina N Tsabai; Maria A Simonova; Vera D Knorre; Yuliana A Mokrushina; Ivan V Smirnov; Julia A Kosolapova; Valentina V Vtorushina; Evgeniya V Inviyaeva; Evgeniya Polushkina; Ulyana L Petrova; Anna V Levadnaya; Lyubov V Krechetova; Roman G Shmakov; Gennadiy T Sukhikh; Alexander G Gabibov
Journal:  Pathogens       Date:  2021-06-05

10.  Large scale analysis of amino acid substitutions in bacterial proteomics.

Authors:  Dmitry Ischenko; Dmitry Alexeev; Egor Shitikov; Alexandra Kanygina; Maja Malakhova; Elena Kostryukova; Andrey Larin; Sergey Kovalchuk; Olga Pobeguts; Ivan Butenko; Nikolay Anikanov; Ilya Altukhov; Elena Ilina; Vadim Govorun
Journal:  BMC Bioinformatics       Date:  2016-11-08       Impact factor: 3.169

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.